- Home
- Pet Ct Scanner Devices Market
PET-CT Scanner Devices Market Research Report - Segmented By Type (Stationary Scanners and Portable/Mobile Scanner), Service Provider (Hospitals, Diagnostic Centers, Research Institutes, Ambulatory Surgical Centers), Slice Count (Low Slice Scanner (<64 Slices), Medium Slice Scanner (64 Slices), and High Slice Scanner (>64 Slices)), and Isotope/Detector Type (Fluorodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium, and Others) Application (Oncology, Neurology, Cardiology, and Others); and Region- Size, Share, Growth Analysis | Forecast (2024 2030)
- Published Date: December, 2023 | Report ID: CLS-2062 | No of pages: 250 | Format:
PET-CT Scanner Devices Market Size (2024-2030)
The Global PET-CT Scanner Devices Market had an estimated worth of USD 2.2 billion in 2023 and is forecasted to achieve USD 3.26 billion by 2030, with an anticipated growth rate of 5.8% during the 2024-2030 forecast period.
Nuclear imaging methods, employing positron emission tomography (PET) scans, scrutinize cellular and tissue functionality. PET-CT scanners merge imaging technologies using radioactive tracers to diagnose metabolic irregularities in the body, offering more accurate assessments compared to standalone scans. These devices have extensive applications, aiding in the diagnosis of various conditions like neurological, gastrointestinal, endocrine, and cardiac ailments. The amalgamation of PET and CT technologies enables precise disease diagnosis, localization, and monitoring. Anticipated technological advancements in the medical sector will likely escalate the demand for PET scanning tools.
Key Market Insights:
GE Healthcare collaborated with SOPHiA GENETICS, a Swiss biotech company, to focus on tailoring cancer care based on individual genetic profiles, aiming for highly effective personalized therapies.
Bruker Corporation announced the acquisition of MOLECUBES NV, enhancing their benchtop preclinical nuclear molecular imaging (NMI) systems, aiming to benefit global NMI clients with superior research and development resources.
GE Healthcare acquired Zionexa to advance the development and marketing of neurology and cancer biomarkers, augmenting individualized treatment approaches and marketing pipeline biomarkers and Cerianna, an FDA-approved imaging agent for breast cancer diagnosis.
Global PET-CT Scanner Devices Market Drivers:
The escalating prevalence of diseases like cancer, Alzheimer's, and cardiovascular disorders worldwide is propelling the demand for medical equipment such as PET-CT scanners.
Innovations focused on enhancing the mobility of these scanners are fueling strong demand, particularly in developed nations. PET-CT scanners provide crucial anatomical and operational data vital for treating cancer patients. Manufacturers are intensifying efforts to develop products tailored for the oncology sector, furthering the growth of the PET-CT scanner devices market. The hospital segment is experiencing substantial expansion due to increased hospital visits for testing, indicating a predicted market growth of PET-CT scanner equipment to approximately US$ 300 million (system only) by 2030, with a projected compound annual growth rate (CAGR) of 3.1%.
Stationary/Portable to Rule Global Market Growth
Regarding the market segmentation based on modality, application, slice count, end-user, and geography, the global PET-CT scanning equipment market has been categorized into various segments. The segments include portable/stationary and bench-top based on modality. With the growing demand for mobile PET-CT equipment, it is anticipated that the portable/stationary category will hold a substantial share of the global market by 2031.
Global PET-CT Scanner Devices Market Challenges:
Installation and maintenance expenses pose significant obstacles to market expansion, particularly in developing nations.
High costs of new technology and strict regulation of reconditioned systems limit their adoption, impacting patient access to affordable imaging services. Reduced payer reimbursement for PET and SPECT treatments globally has led to lower outpatient volumes, hindering patient access to high-quality diagnostic services.
Global PET-CT Scanner Devices Market Opportunities:
The increasing incidence of chronic and infectious diseases, particularly cancer and heart ailments, offers opportunities for improved diagnostic tools. Rising cancer cases and technological advancements in scanners enabling quicker scans and better localization of abnormal activity provide scope for market expansion. The rise in brain disorders such as Alzheimer's and traumatic brain injury also contributes to market growth, with improved scanner technology aiding in faster scans and better localization of activity.
Global PET-CT Scanner Devices Market Segmentation:
By Type:
Stationary Scanners
Portable/Mobile Scanner
The PET-CT Scanner Device Market is categorized into stationary scanners and portable/mobile scanners segments. Notably, the Portable Scanners/Mobile Scanners segment led in revenue within the market due to increasing adoption by small and medium-sized healthcare organizations. The preference for mobile devices is attributed to their cost-effectiveness, rapid installation, lower initial investments, and reduced patient travel. Leading manufacturers such as GE, Philips, and Siemens offer a diverse range of portable PET-CT scanners.
By Slice Count:
Low Slice Scanner (<64 Slices)
Medium Slice Scanner (64 Slices)
High Slice Scanner (>64 Slices)
The PET-CT Scanner Device Market is divided into Low (<64 slices), Medium (64 slices), and High (>64 slices) segments based on the number of slices. The Low Slice Cardiology sector held a significant revenue share in the market, largely due to the increased prevalence of medical implants, sedentary lifestyles, and evolving dietary habits. Continuous research and development efforts are expected to drive further growth in this segment by advancing imaging technologies.
By Isotope/Detector Type:
Fluorodeoxyglucose (FDG)
62Cu ATSM
18 F Sodium Fluoride
FMISO
Gallium
Thallium
Others
The market segments based on Isotope/Detector Type include Fluorodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium, and Others. Notably, the largest revenue share in the PET-CT scanner devices market was attributed to the fluorodeoxyglucose (FDG) category. FDG, a common radiotracer, is absorbed by cancer cells, indicating its increased use driven by rising chronic illnesses, decreased side effects, and expanded applications, offering enhanced precision and detail.
By Service Provider:
Hospitals
Diagnostic Centers
Research Institutes
Ambulatory Surgical Centers
Service providers in the PET-CT Scanner Device Market are divided into hospitals, diagnostic centers, research institutes, and ambulatory surgical centers. Hospitals dominated the market share at 35%, fueled by increased patient confidence in hospital-based treatments and the growing utilization of PET-CT scanners. The segment is poised for growth, driven by the shift to minimally invasive surgeries and outpatient procedures. Ambulatory surgical centers are expected to witness substantial growth due to the swift adoption of PET-CT scanners for pre-operative and post-operative evaluations.
By Application:
Oncology
Neurology
Cardiology
Others
Applications in the PET-CT Scanner Device Market encompass Oncology, Cardiology, Neurology, and Others. Notably, the Cardiology sector dominated the market at 28%, showcasing the significance of cardiac PET/CT in diagnosing coronary artery disease with higher precision and lower radiation exposure. The oncology segment is projected to grow rapidly due to rising cancer prevalence, the need for non-invasive imaging, technological advancements, and increased adoption in cancer research.
By Region:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
The global PET-CT scanner device market is segmented into North America, Europe, Asia-Pacific, South America, the Middle East, and Africa. North America is anticipated to hold a leading position owing to the increasing number of traumatic brain injury cases. Europe is poised for considerable growth with significant contributions from established industry players and an extensive network of installed devices. The Asia-Pacific region is expected to witness rapid expansion due to better medical infrastructure, increased hospitals equipped with advanced scanning technologies, expanded research and development, and improved healthcare facilities.
COVID-19 Impact on Global PET-CT Scanner Devices Market:
The utilization of PET imaging has facilitated tracking key pathophysiological changes in COVID-19, offering vital insights for diagnosis, assessment, and management. F-labeled fluorodeoxyglucose (18F-FDG) has been widely employed in COVID-19 patients, leveraging PET/CT systems to concurrently evaluate structural and functional alterations. The market for PET-CT scanner devices experienced a positive impact due to their role in COVID-19 diagnosis, treatment, and the heightened concerns of cancer patients. The growth was bolstered by increased PET-CT scan usage, particularly among patients undergoing radiation therapy, and heightened concerns among cancer patients regarding COVID-19's impact, driving the demand for PET CT scanning equipment.
Global PET-CT Scanner Devices Market Recent Developments:
GE Healthcare introduced Xeleris V, an innovative virtual processing and review system, streamlining data access for physicians. Shimadzu Corporation unveiled the BresTome TOF-PET, a functional imaging system for head and breast applications. Siemens Healthineers introduced Biograph Vision Quadra, a CE-Marked PET/CT scanner for translational research and clinical use. These developments signify the ongoing advancements and innovations in PET-CT scanning technology.
Key Players:
- Bruker Corporation
- Siemens Healthineers
- Koninklijke Philips N.V
- GE Healthcare
- Mediso Ltd.
- MinFound Medical Systems Co., Ltd
- MR Solutions
- Neusoft Corporation
- SOFIE
- Canon, Inc
- United Imaging Healthcare Co
In January 2022, Neusoft Medical Systems, a leading global provider of clinical diagnostic solutions, joined forces with Positron Corporation to collaborate on the development, distribution, and advancement of Positron's groundbreaking PET/CT nuclear imaging technology. Through this alliance, the two entities aimed to merge their nuclear cardiology services and PET/CT technologies, augmenting their clinical services and diagnostic capabilities particularly in cancer imaging.
TABLE OF CONTENT
Chapter 1. PET-CT Scanner Devices Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. PET-CT Scanner Devices Market – Executive Summary
2.1 Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. PET-CT Scanner Devices Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. PET-CT Scanner Devices Market - Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. PET-CT Scanner Devices Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. PET-CT Scanner Devices Market – By Type
6.1 Introduction/Key Findings
6.2 Stationary Scanners
6.3 Portable/Mobile Scanner
6.4 Y-O-Y Growth trend Analysis By Type
6.5 Absolute $ Opportunity Analysis By Type, 2023-2030
Chapter 7. PET-CT Scanner Devices Market – By Slice Count
7.1 Introduction/Key Findings
7.2 Low Slice Scanner (<64 Slices)
7.3 Medium Slice Scanner (64 Slices)
7.4 High Slice Scanner (>64 Slices)
7.5 Y-O-Y Growth trend Analysis By Slice Count
7.6 Absolute $ Opportunity Analysis By Slice Count, 2023-2030
Chapter 8. PET-CT Scanner Devices Market – By Isotope/Detector Type
8.1 Introduction/Key Findings
8.2 Fluorodeoxyglucose (FDG)
8.3 62Cu ATSM
8.4 18 F Sodium Fluoride
8.5 FMISO
8.6 Gallium
8.7 Thallium
8.8 Others
8.9 Y-O-Y Growth trend Analysis By Isotope/Detector Type
8.10 Absolute $ Opportunity Analysis By Isotope/Detector Type, 2023-2030
Chapter 9. PET-CT Scanner Devices Market – By Application
9.1 Introduction/Key Findings
9.2 Oncology
9.3 Neurology
9.4 Cardiology
9.5 Others
9.6 Y-O-Y Growth trend Analysis By Application
9.7 Absolute $ Opportunity Analysis By Application, 2023-2030
Chapter 10. PET-CT Scanner Devices Market – By Service Provider
10.1 Introduction/Key Findings
10.2 Hospitals
10.3 Diagnostic Centers
10.4 Research Institutes
10.5 Ambulatory Surgical Centers
10.6 Y-O-Y Growth trend Analysis By Service Provider
10.7 Absolute $ Opportunity Analysis By Service Provider, 2023-2030
Chapter 11. PET-CT Scanner Devices Market, By Geography – Market Size, Forecast, Trends & Insights
11.1 North America
11.1.1 By Country
11.1.1.1 U.S.A.
11.1.1.2 Canada
11.1.1.3 Mexico
11.1.2 By Type
11.1.2.1 By Slice Count
11.1.3 By Isotope/Detector Type
11.1.4 By Service Provider
11.1.5 Countries & Segments - Market Attractiveness Analysis
11.2 Europe
11.2.1 By Country
11.2.1.1 U.K
11.2.1.2 Germany
11.2.1.3 France
11.2.1.4 Italy
11.2.1.5 Spain
11.2.1.6 Rest of Europe
11.2.2 By Type
11.2.3 By Slice Count
11.2.4 By Isotope/Detector Type
11.2.5 By Application
11.2.6 By Service Provider
11.2.7 Countries & Segments - Market Attractiveness Analysis
11.3 Asia Pacific
11.3.1 By Country
11.3.1.1 China
11.3.1.2 Japan
11.3.1.3 South Korea
11.3.1.4 India
11.3.1.5 Australia & New Zealand
11.3.1.6 Rest of Asia-Pacific
11.3.2 By Type
11.3.3 By Slice Count
11.3.4 By Isotope/Detector Type
11.3.5 By Application
11.3.6 By Service Provider
11.3.7 Countries & Segments - Market Attractiveness Analysis
11.4 South America
11.4.1 By Country
11.4.1.1 Brazil
11.4.1.2 Argentina
11.4.1.3 Colombia
11.4.1.4 Chile
11.4.1.5 Rest of South America
11.4.2 By Type
11.4.3 By Slice Count
11.4.4 By Isotope/Detector Type
11.4.5 By Application
11.4.6 By Service Provider
11.4.7 Countries & Segments - Market Attractiveness Analysis
11.5 Middle East & Africa
11.5.1 By Country
11.5.1.1 United Arab Emirates (UAE)
11.5.1.2 Saudi Arabia
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 South Africa
11.5.1.6 Nigeria
11.5.1.7 Kenya
11.5.1.8 Egypt
11.5.1.9 Rest of MEA
11.5.2 By Type
11.5.3 By Slice Count
11.5.4 By Isotope/Detector Type
11.5.5 By Application
11.5.6 By Service Provider
11.5.7 Countries & Segments - Market Attractiveness Analysis
Chapter 12. PET-CT Scanner Devices Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
12.1 Bruker Corporation
12.2 Siemens Healthineers
12.3 Koninklijke Philips N.V
12.4 GE Healthcare
12.5 Mediso Ltd.
12.6 MinFound Medical Systems Co., Ltd
12.7 MR Solutions
12.8 Neusoft Corporation
12.9 SOFIE
12.10 Canon, Inc
12.11 United Imaging Healthcare Co
Segmentation
Global PET-CT Scanner Devices Market Segmentation:
By Type:
Stationary Scanners
Portable/Mobile Scanner
The PET-CT Scanner Device Market is categorized into stationary scanners and portable/mobile scanners segments. Notably, the Portable Scanners/Mobile Scanners segment led in revenue within the market due to increasing adoption by small and medium-sized healthcare organizations. The preference for mobile devices is attributed to their cost-effectiveness, rapid installation, lower initial investments, and reduced patient travel. Leading manufacturers such as GE, Philips, and Siemens offer a diverse range of portable PET-CT scanners.
By Slice Count:
Low Slice Scanner (<64 Slices)
Medium Slice Scanner (64 Slices)
High Slice Scanner (>64 Slices)
The PET-CT Scanner Device Market is divided into Low (<64 slices), Medium (64 slices), and High (>64 slices) segments based on the number of slices. The Low Slice Cardiology sector held a significant revenue share in the market, largely due to the increased prevalence of medical implants, sedentary lifestyles, and evolving dietary habits. Continuous research and development efforts are expected to drive further growth in this segment by advancing imaging technologies.
By Isotope/Detector Type:
Fluorodeoxyglucose (FDG)
62Cu ATSM
18 F Sodium Fluoride
FMISO
Gallium
Thallium
Others
The market segments based on Isotope/Detector Type include Fluorodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium, and Others. Notably, the largest revenue share in the PET-CT scanner devices market was attributed to the fluorodeoxyglucose (FDG) category. FDG, a common radiotracer, is absorbed by cancer cells, indicating its increased use driven by rising chronic illnesses, decreased side effects, and expanded applications, offering enhanced precision and detail.
By Service Provider:
Hospitals
Diagnostic Centers
Research Institutes
Ambulatory Surgical Centers
Service providers in the PET-CT Scanner Device Market are divided into hospitals, diagnostic centers, research institutes, and ambulatory surgical centers. Hospitals dominated the market share at 35%, fueled by increased patient confidence in hospital-based treatments and the growing utilization of PET-CT scanners. The segment is poised for growth, driven by the shift to minimally invasive surgeries and outpatient procedures. Ambulatory surgical centers are expected to witness substantial growth due to the swift adoption of PET-CT scanners for pre-operative and post-operative evaluations.
By Application:
Oncology
Neurology
Cardiology
Others
Applications in the PET-CT Scanner Device Market encompass Oncology, Cardiology, Neurology, and Others. Notably, the Cardiology sector dominated the market at 28%, showcasing the significance of cardiac PET/CT in diagnosing coronary artery disease with higher precision and lower radiation exposure. The oncology segment is projected to grow rapidly due to rising cancer prevalence, the need for non-invasive imaging, technological advancements, and increased adoption in cancer research.
By Region:
North America
Europe
Asia-Pacific
South America
Middle East and Africa
The global PET-CT scanner device market is segmented into North America, Europe, Asia-Pacific, South America, the Middle East, and Africa. North America is anticipated to hold a leading position owing to the increasing number of traumatic brain injury cases. Europe is poised for considerable growth with significant contributions from established industry players and an extensive network of installed devices. The Asia-Pacific region is expected to witness rapid expansion due to better medical infrastructure, increased hospitals equipped with advanced scanning technologies, expanded research and development, and improved healthcare facilities.
COVID-19 Impact on Global PET-CT Scanner Devices Market:
The utilization of PET imaging has facilitated tracking key pathophysiological changes in COVID-19, offering vital insights for diagnosis, assessment, and management. F-labeled fluorodeoxyglucose (18F-FDG) has been widely employed in COVID-19 patients, leveraging PET/CT systems to concurrently evaluate structural and functional alterations. The market for PET-CT scanner devices experienced a positive impact due to their role in COVID-19 diagnosis, treatment, and the heightened concerns of cancer patients. The growth was bolstered by increased PET-CT scan usage, particularly among patients undergoing radiation therapy, and heightened concerns among cancer patients regarding COVID-19's impact, driving the demand for PET CT scanning equipment.
Global PET-CT Scanner Devices Market Recent Developments:
GE Healthcare introduced Xeleris V, an innovative virtual processing and review system, streamlining data access for physicians. Shimadzu Corporation unveiled the BresTome TOF-PET, a functional imaging system for head and breast applications. Siemens Healthineers introduced Biograph Vision Quadra, a CE-Marked PET/CT scanner for translational research and clinical use. These developments signify the ongoing advancements and innovations in PET-CT scanning technology.
Key Players:
- Bruker Corporation
- Siemens Healthineers
- Koninklijke Philips N.V
- GE Healthcare
- Mediso Ltd.
- MinFound Medical Systems Co., Ltd
- MR Solutions
- Neusoft Corporation
- SOFIE
- Canon, Inc
- United Imaging Healthcare Co
In January 2022, Neusoft Medical Systems, a leading global provider of clinical diagnostic solutions, joined forces with Positron Corporation to collaborate on the development, distribution, and advancement of Positron's groundbreaking PET/CT nuclear imaging technology. Through this alliance, the two entities aimed to merge their nuclear cardiology services and PET/CT technologies, augmenting their clinical services and diagnostic capabilities particularly in cancer imaging.
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.